Landsberg Bennett & Dubbaneh’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $826K | Buy |
7,575
+67
| +0.9% | +$7.31K | 0.11% | 132 |
|
|
2021
Q2 | $843K | Buy |
7,508
+30
| +0.4% | +$3.37K | 0.11% | 136 |
|
|
2021
Q1 | $812K | Buy |
7,478
+431
| +6% | +$46.8K | 0.12% | 131 |
|
|
2020
Q4 | $755K | Buy |
7,047
+43
| +0.6% | +$4.61K | 0.12% | 122 |
|
|
2020
Q3 | $609K | Buy |
7,004
+182
| +3% | +$15.8K | 0.11% | 130 |
|
|
2020
Q2 | $658K | Buy |
6,822
+564
| +9% | +$54.4K | 0.14% | 130 |
|
|
2020
Q1 | $470K | Buy |
6,258
+213
| +4% | +$16K | 0.13% | 114 |
|
|
2019
Q4 | $535K | Buy |
6,045
+5
| +0.1% | +$443 | 0.13% | 141 |
|
|
2019
Q3 | $452K | Sell |
6,040
-743
| -11% | -$55.6K | 0.12% | 147 |
|
|
2019
Q2 | $498K | Sell |
6,783
-496
| -7% | -$36.4K | 0.13% | 150 |
|
|
2019
Q1 | $605K | Sell |
7,279
-17,287
| -70% | -$1.44M | 0.14% | 142 |
|
|
2018
Q4 | $2.27M | Buy |
+24,566
| New | +$2.27M | 0.87% | 31 |
|